|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 12/12/14 Origo Acquisition Corp EFFECT 12/12/14 1:2K SEC |
Document/Exhibit Description Pages Size 1: EFFECT Notice of Effectiveness -- primary_doc.xml/1.1 HTML 3K
| Original SGML Text submitted by: | SEC #5 (as Filing Agent) |
|---|
<SUBMISSION> <SECRELEASE-DATETIME> 20141215-060054 ⇐ Metadata from SEC Info (ET) <SECWEBSITE-DATETIME> 20141215-060054 ⇐ Metadata from SEC Info (ET) <ACCEPTANCE-DATETIME> 20141215-001519 ⇐ Filing accepted by SEC (ET) <ACCESSION-NUMBER> 9999999995-14-003680 <TYPE> EFFECT <PUBLIC-DOCUMENT-COUNT> 1 <FILING-DATE> 20141212 <DATE-OF-FILING-DATE-CHANGE> 20141215 <EFFECTIVENESS-DATE> 20141212 |
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> CB Pharma Acquisition Corp.
<CIK> 0001619551
<ASSIGNED-SIC> 6770
<IRS-NUMBER> 000000000
<STATE-OF-INCORPORATION> E9 ⇐ This is an SEC Country/Territory Code for
Cayman Islands [ U.K. ] {KY|CYM}
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> EFFECT
<ACT> 33
<FILE-NUMBER> 333-199558
<FILM-NUMBER> 141284902
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 24 NEW ENGLAND EXECUTIVE PARK
<STREET2> SUITE 105
<CITY> BURLINGTON
<STATE> MA
<ZIP> 01803
<PHONE> 781-652-4500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 24 NEW ENGLAND EXECUTIVE PARK
<STREET2> SUITE 105
<CITY> BURLINGTON
<STATE> MA
<ZIP> 01803
</MAIL-ADDRESS>
</FILER>
|
<DOCUMENT> <TYPE> EFFECT <SEQUENCE> 1 <FILENAME> primary_doc.xml <TEXT> <XML> <?xml version="1.0"?> Show <XML>: 24 lines (widest: 75 characters) - 610 bytes </TEXT> </DOCUMENT> |
</SUBMISSION> |
| ↑Top |